See related Leukeran film-coated tab information 
 
Manufacturer Aspen Pharmacare 
Distributor Hong Kong: Primal 
Contents Chlorambucil
Indications Hodgkin's disease. Certain forms of non-Hodgkin's lymphoma. Chronic lymphocytic leukaemia, Waldenstrom's macroglobulinaemia, advanced ovarian adenocarcinoma, breast cancer in a proportion of patients.
Dosage Hodgkin's disease Monotherapy: 0.2 mg/kg/day for 4-8 wk. Non-Hodgkin's lymphoma Monotherapy: 0.1-0.2 mg/kg/day for 4-8 wk initially. Chronic lymphocytic leukaemia 0.15 mg/kg/day until the total leucocyte count has fallen to 10,000/microlitre. Treatment may be resumed 4 wk after the end of the 1st course & continued at 0.1 mg/kg/day. Waldenstrom's macroglobulinaemia Starting dose: 6-12 mg daily until leucopenia occurs; followed by 2-8 mg daily indefinitely. Ovarian carcinoma Monotherapy: 0.2 mg/kg/day for 4-6 wk, Maintenance course: 0.2 mg/kg/day for 2-4 wk w/ 2-6 wk intervals between each course. Advanced breast cancer Monotherapy 0.2 mg/kg/day for 6 wk. Combination therapy w/ prednisolone, methotrexate or 5-fluorouracil 5-7.5 mg/m2/day.
Administration Should be taken on an empty stomach (Take on an empty stomach. Ensure adequate hydration. Swallow whole, do not chew/crush.).
Contraindications Pregnancy (1st trimester) & lactation.
Special Precautions Immunisation using a live organism vaccine has the potential to cause infection in immunocompromised host. Monitor blood counts closely; should not be given to patients who have recently undergone radiotoxic or chemotherapy. In lymphocytic infiltration of bone marrow, daily dose should not >0.1 mg/kg body wt. Renal or hepatic impairment. Childn w/ nephrotic syndrome, patients prescribed high pulse dosing regimens & patients w/ history of seizure disorder. Acute secondary haematologic malignancies. Ensure adequate contraceptive precautions.
Adverse Drug Reactions Acute secondary haematologic malignancies esp leukaemia & myelodysplastic syndrome; leucopenia, neutropenia, thrombocytopenia, pancytopenia, bone marrow suppression, anaemia; seizures in childn w/ nephrotic syndrome; nausea, vomiting, diarrhoea, oral ulceration; rash. Rarely, irreversible bone marrow failure, allergic reactions, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, movement disorders, peripheral neuropathy, interstitial pulmonary fibrosis, interstitial pneumonia, hepatotoxicity, jaundice, sterile cystitis, drug fever.
View ADR Monitoring Form
Drug Interactions Live organism vaccines, phenylbutazone.
View more drug interactions with Leukeran
Pregnancy Category (US FDA)      
     
Category D: There is positive evidence of human foetal risk, but the benefits from use in pregnant women may be acceptable despite the risk (e.g., if the drug is needed in a life-threatening situation or for a serious disease for which safer drugs cannot be used or are ineffective). 
ATC Classification L01AA02 - chlorambucil ; Belongs to the class of alkylating agents, nitrogen mustard analogues. Used in the treatment of cancer. 

Presentation/Packing
Form Packing Photo
Leukeran film-coated tablet  Leukeran 2 mg x 25's 

 
Manufacturer: Aspen Pharmacare
 
Distributor: Hong Kong: Primal